Mike Knapton

About
Latest Posts

Dr at British Heart Foundation

Dr Mike Knapton is the associate medical director of the British Heart Foundation and a practising GP based in Cambridge.

Cascade testing for genetic heart conditions

Coronavirus, COVID-19 Update, Heart & Lung, Infection/Disease, Innovation
ECMO Proto Device fights Covid-19
Shandong University Researchers Develop ECMO Proto Device in Aid of Fighting COVID-19. After the COVID-19 outbreak, the name ECMO (Extracorporeal Membrane Oxygenation) has caught the eyes of the public. Regarded …
Heart & Lung, Heart Disease
$6.5 million for research project on cardiovascular …
Christoph Binder, Professor of Atherosclerosis Research at MedUni Vienna, is to coordinate an international research network investigating the role of B cells in cardiovascular disease. The project is being funded …
Heart & Lung, Heart Disease, Paediatrics
Diet and activity reduces cholesterol in kids
New study shows that dietary and physical activity intervention reduces LDL cholesterol level in children. An individualised and family-based physical activity and dietary intervention reduced the plasma LDL cholesterol concentration …
Cancer, genetics, Infection/Disease, Men's Health
Feasibility of genetic screening for prostate cancer
Feasibility of genetic screening for prostate cancer Genetic ‘barcoding’ in GP surgeries picks out men at increased risk for follow-up checks Pilot study shows population screening is feasible …
Coronavirus, COVID-19 Update, Heart & Lung, Infection/Disease
Over half of smokers in England want …
Over half (53%) of current smokers with lung conditions were planning to quit smoking due to COVID -19 in May, finds survey by Asthma UK and the British Lung Foundation. …

The Royal Society of Medicine blogs

View all posts from The RSM »

LATEST: Management of Chronic Pain